Immuneering
Immuneering is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying translational bioinformatics to every stage of the drug development process.

Year Established: 2009
Stock Ticker: IMRX
Exchange: NASDAQ
